Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

Quandary for U.S. companies: Whom to bribe? (Washington Post)

WV3Cover

From this Sunday’s Washington Post, David Hilzenrath lays out ambiguities of the Foreign Corrupt Practices Act. Scientific American’s Worldview 2011 report compares corruption among countries seeking to grow the biotech industry within their borders based on the 2010 Corruption Perceptions Index from Transparency International. Countries that ranked high in perceived corruption tended to rank lower in terms of overall innovation. In other words, as corruption increases, the nation’s business reputation sinks while those with a Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , ,

Public Opinion: What do voters think about biotechnology?

Graph

The majority of voters recognize the important work being conducted at biotech companies and place a high value on the industry’s contributions. After only a brief neutral description of the biotechnology industry, 87% of those polled have a favorable image of the biotech industry. More than three-quarters of Americans surveyed are convinced that biotech is working every day on curing diseases such as Alzheimer’s, cancer, diabetes and Parinson’s. Furthermore, they believe that these cures will Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

International groups put the “International” in BIO International Convention

Drum Performance

The international presence at the global event for biotechnology was in full-force this year, with more than 5,400 international attendees. This year’s Convention attracted more than 100 international public officials and numerous international delegations touting the benefits of investing in biotech within their borders. Some highlights: Canada Canada continues to hold the number one spot for the largest international delegation at the Convention. More than 750 attendees and numerous Premiers, Ministers, Mayors and other leaders Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Podcast: Humanitarian Award Winner Dr. Paul Offit

photo

During the 2011 BIO International Convention, Paul A. Offit, MD, Chief of the Division of Infectious Diseases and the Director of the Vaccine Education Center at The Children’s Hospital of Philadelphia, was named the 2011 Biotech Humanitarian Award winner. Dr. Offit was selected as the 2011 Honoree in recognition of his 25 years spent dedicated to developing RotaTeq, one of the main vaccines currently used to fight rotavirus, a disease that is the leading cause Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Podcast: 2011 Dr. Paul Janssen Award winner Dr. Napoleone Ferrara

JOHNSON & JOHNSON DR. PAUL JANSSEN FOR BIOMEDICAL RESEARCH AWARD WINNER

Dr. Napoleone Ferrara, a Genentech Fellow, was named the 2011 winner of The Dr. Paul Janssen Award for Biomedical Research. Dr. Ferrrara was recognized for his research on angiogenesis, the process of new blood vessel formation, and the isolation and cloning of vascular endothelial growth factor (VEGF), a major regulator of angiogenesis in physiology and disease. Download the podcast

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,